Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species for therapeutic applications.

The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.

Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in February.

Johanna Joyce, PhD, then took the rostrum and spoke eloquently on the tumor microenvironment, underscoring the immense ...

Senator Tammy Baldwin showed unwavering support for scientific funding when she accepted the AACR Distinguished Public Service Award.

GEN's Julianna LeMieux and IPM's Damian Doherty provide highlights of the first day of the AACR 2025 meeting in Chicago.

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.

Integrating a cell line development capability into Cytiva’s biomanufacturing technologies could enhance a customer's ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...